The Prevalence of Symptomatic Dermographism: Results of the International <scp>UCARE PREVALENCE</scp> ‐D Study
Kanokvalai Kulthanan(Siriraj Hospital), Papapit Tuchinda(Siriraj Hospital), Pavel Kolkhir(Fraunhofer Institute for Translational Medicine and Pharmacology), Anastasiia Allenova(Sechenov University), Michael Rudenko, Iván Chérrez-Ojeda(University of Guayaquil), Pascale Salameh(Lebanese University), Joanna Bartosińska(Medical University of Lublin), Roberta Fachini Jardim Criado(Faculdade de Medicina do ABC), Maryam Khoshkhui(Mashhad University of Medical Sciences), Ana Presa(Centro Hospitalar do Tâmega e Sousa), Melba Muñoz(Humboldt-Universität zu Berlin), Chulaluk Komoltri(Siriraj Hospital), Dragan Mijakoski(Institute of public health of Republic of Macedonia), César A. Galván(International Potato Center), Rabia Öztaş Kara(Sakarya University), Luís Felipe Ensina(Universidade Federal de São Paulo), Yanisorn Nanchaipruek(Siriraj Hospital), Rana Tafrishi(Mashhad University of Medical Sciences), Indrashis Podder(College of Medicine & Sagore Dutta Hospital), Natasa Teovska‐Mitrevska(Institute of public health of Republic of Macedonia), Maia Gotua(Evangelisches Krankenhaus Bielefeld), Nuttagarn Jantanapornchai(Siriraj Hospital), Dorota Krasowska(Medical University of Lublin), Chuda Rujitharanawong(Siriraj Hospital), Saad Alshareef(King Faisal Specialist Hospital & Research Centre), Kiran Godse(D.Y. Patil University), Ana M. Giménez‐Arnau(Universitat Pompeu Fabra), Nasser Al‐Ahmed(Ministry of Health), Mona Al‐Ahmad(Ministry of Health), Rand Arnaout(King Faisal Specialist Hospital & Research Centre), Iman Nasr(Royal Hospital), Karla Robles‐Velasco(Universidad Espíritu Santo), Waratchaya Panjapakkul(Siriraj Hospital), Esra Adışen(Gazi University), Jonathan A. Bernstein(Bernstein Clinical Research Center), Salma Al-Abri(Royal Hospital), Raisa Meshkova(Smolensk State Medical University), Paulo Ricardo Criado(Faculdade de Medicina do ABC), Nattha Angkoolpakdeekul(Siriraj Hospital), Naoko Inomata(Yokohama City University), Chang‐Gyu Jung(Keimyung University), Teerapat Paringkarn(Siriraj Hospital), Phuwakorn Saengthong‐aram(Siriraj Hospital), Bushra Al Hinai(Royal Hospital), Isabel Rosmaninho(Administração Regional de Saúde de Lisboa e Vale do Tejo), Jomgriditip Laomoleethorn(Siriraj Hospital), Leena Chularojanamontri(Siriraj Hospital), Antonina Maiorowa(Smolensk State Medical University), Alicja Kasperska−Zając(Medical University of Silesia)
Cited by 7
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723